Loading...

Asymchem Laboratories (Tianjin) Co., Ltd.

6821.HKHKSE
HealthcareBiotechnology
HK$71.40
HK$0.70(0.99%)

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) Financial Performance & Statements

Review Asymchem Laboratories (Tianjin) Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.

Revenue Growth
-25.82%
25.82%
Operating Income Growth
-58.04%
58.04%
Net Income Growth
-58.17%
58.17%
Operating Cash Flow Growth
-64.66%
64.66%
Operating Margin
19.22%
19.22%
Gross Margin
42.13%
42.13%
Net Profit Margin
16.71%
16.71%
ROE
5.93%
5.93%
ROIC
6.39%
6.39%

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) Financial Statements

Explore quarterly and annual reports including balance sheet, income statement, cash flow for Asymchem Laboratories (Tianjin) Co., Ltd. stock.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$1.66B$1.44B$1.28B$1.36B
Cost of Revenue$1.01B$774.59M$800.97M$790.60M
Gross Profit$653.47M$668.35M$480.93M$568.18M
Gross Profit Ratio$0.39$0.46$0.38$0.42
R&D Expenses$130.35M$155.45M$153.23M$169.44M
SG&A Expenses-$370.64M$536.77M$217.12M$215.70M
Operating Expenses$336.27M$439.82M$379.25M$385.14M
Total Costs & Expenses$1.35B$1.21B$1.18B$1.18B
Interest Income$43.02M$54.87M$183.10M$62.40M
Interest Expense$5.81M$1.16M$1.96M$572586.00
Depreciation & Amortization$0.00-$12.38M$127.16M$105.52M
EBITDA$319.04M$227.67M$372.24M$422.73M
EBITDA Ratio$0.19$0.16$0.29$0.31
Operating Income$317.21M$240.05M$101.68M$183.04M
Operating Income Ratio$0.19$0.17$0.08$0.13
Other Income/Expenses (Net)-$3.98M-$10.02M-$256314.00-$25011.00
Income Before Tax$313.23M$230.03M$243.12M$294.99M
Income Before Tax Ratio$0.19$0.16$0.19$0.22
Income Tax Expense$77.65M$18.74M$25.10M$15.13M
Net Income$238.62M$211.19M$217.16M$281.97M
Net Income Ratio$0.14$0.15$0.17$0.21
EPS$0.68$0.60$0.64$0.76
Diluted EPS$0.68$0.60$0.64$0.76
Weighted Avg Shares Outstanding$352.77M$354.88M$341.005M$369.47M
Weighted Avg Shares Outstanding (Diluted)$352.77M$354.88M$341.005M$369.47M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions